.Innovent Biologics has helped make the case that its own checkpoint inhibitor-cytokine fusion prote...
.A phase 3 test of Daiichi Sankyo and also Merck & Co.'s HER3-directed antibody-drug conjugate (A...
.Five months after Rakovina Therapeutics pivoted towards expert system, the cancer-focused biotech h...
.Ascendis Pharma has emerged as a potential threat to BioMarin's Voxzogo, disclosing period 3 develo...
.Though Alkeus Pharmaceuticals' oral eye health condition resource fell short to dramatically lower ...
.Along with a trio of biotechs striking the Nasdaq on Friday, it was actually quick and easy to over...
.Invulnerable gate inhibitors are the superheroes of cancer cells therapy. Medicines like Bristol My...
.Accept to this week's Chutes & Ladders, our roundup of considerable management hirings, shooting...
.Regeneron is actually back with long-lasting follow-up for its own LAG-3 prevention and also PD-1 p...
.AstraZeneca has discussed a very early look at the performance of its internal antibody-drug conjug...